Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TEPROTUMUMAB-TRBW: 4,942 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
4,942
Total FAERS Reports
26 (0.5%)
Deaths Reported
368
Hospitalizations
4,942
As Primary/Secondary Suspect
20
Life-Threatening
301
Disabilities
Prescription
Status

FDA Application: 761143 ·

First Report: 20000101 · Latest Report: 20250821

What Are the Most Common TEPROTUMUMAB-TRBW Side Effects?

#1 Most Reported
Muscle spasms
998 reports (20.2%)
#2 Most Reported
Fatigue
704 reports (14.2%)
#3 Most Reported
Tinnitus
524 reports (10.6%)

All TEPROTUMUMAB-TRBW Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Muscle spasms 998 20.2% 1 66
Fatigue 704 14.3% 4 82
Tinnitus 524 10.6% 1 36
Headache 443 9.0% 1 49
Hypoacusis 430 8.7% 0 15
Diarrhoea 408 8.3% 2 63
Nausea 407 8.2% 1 55
Blood glucose increased 401 8.1% 0 77
Alopecia 390 7.9% 0 24
Pain 344 7.0% 1 38
Anxiety 329 6.7% 1 40
Diplopia 294 6.0% 0 23
Emotional distress 278 5.6% 1 29
Weight decreased 276 5.6% 2 44
Drug ineffective 274 5.5% 1 12
Endocrine ophthalmopathy 245 5.0% 0 24
Blood pressure increased 244 4.9% 4 51
Diabetes mellitus 229 4.6% 1 35
Discomfort 228 4.6% 1 24
Deafness 221 4.5% 0 4

Who Reports TEPROTUMUMAB-TRBW Side Effects? Age & Gender Data

Gender: 73.4% female, 26.6% male. Average age: 58.2 years. Most reports from: US. View detailed demographics →

Is TEPROTUMUMAB-TRBW Getting Safer? Reports by Year

YearReportsDeathsHosp.
2000 1 0 0
2002 1 0 0
2003 1 0 0
2012 2 0 0
2013 2 0 1
2014 2 0 0
2015 2 0 1
2016 2 0 1
2017 1 0 1
2018 6 0 1
2019 7 0 3
2020 238 1 27
2021 291 5 32
2022 422 0 72
2023 417 1 69
2024 387 3 27
2025 89 0 13

View full timeline →

What Is TEPROTUMUMAB-TRBW Used For?

IndicationReports
Endocrine ophthalmopathy 2,523
Product used for unknown indication 2,040
Toxic goitre 367
Graves' disease 267
Basedow's disease 65
Hyperthyroidism 47
Exophthalmos 27
Diplopia 12
Eye disorder 10
Thyroid disorder 9

TEPROTUMUMAB-TRBW vs Alternatives: Which Is Safer?

TEPROTUMUMAB-TRBW vs TERAZOSIN TEPROTUMUMAB-TRBW vs TERAZOSIN\TERAZOSIN TEPROTUMUMAB-TRBW vs TERBINAFINE TEPROTUMUMAB-TRBW vs TERBINAFINE\TERBINAFINE TEPROTUMUMAB-TRBW vs TERBUTALINE TEPROTUMUMAB-TRBW vs TERCONAZOLE TEPROTUMUMAB-TRBW vs TERIFLUNOMIDE TEPROTUMUMAB-TRBW vs TERIPARATIDE TEPROTUMUMAB-TRBW vs TERIZIDONE TEPROTUMUMAB-TRBW vs TERLIPRESSIN

Official FDA Label for TEPROTUMUMAB-TRBW

Official prescribing information from the FDA-approved drug label.